A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models.

Autor: Loontiens S; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Vanhauwaert S; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Depestel L; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Dewyn G; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Van Loocke W; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Moore FE; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center of Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center of Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Garcia EG; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center of Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center of Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Batchelor L; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Borga C; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Squiban B; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Malone-Perez M; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Volders PJ; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Olexiouk V; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Van Vlierberghe P; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Langenau DM; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center of Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center of Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Frazer JK; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Durinck K; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. Kaat.durinck@ugent.be.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium. Kaat.durinck@ugent.be., Speleman F; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Jazyk: angličtina
Zdroj: Leukemia [Leukemia] 2020 Dec; Vol. 34 (12), pp. 3398-3403. Date of Electronic Publication: 2020 Jun 26.
DOI: 10.1038/s41375-020-0938-2
Databáze: MEDLINE